SCHEMBL2181035

SCHEMBL2181035

CCN(CC)CCOc1nnc2c(n1)c(=O)n(C)c(=O)n2Cc1cccnc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 3/20 0.46
PKM P14618 2/20 0.44
ALDH1A1 P00352 4/20 0.44
HTT P42858 1/20 0.44
NPSR1 Q6W5P4 2/20 0.43
MAPT P10636 1/20 0.43
MAPK1 P28482 2/20 0.41
GRIN1 Q05586 8/20 0.40
GRIN2B Q13224 8/20 0.40
TLR7 Q9NYK1 2/20 0.40
POLB P06746 1/20 0.39
HPGD P15428 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
GAA P10253 1/20 0.39
TSHR P16473 1/20 0.39
ADORA3 P0DMS8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2182798 0.95 HIF1A (0.45) HIF1APKMALDH1A1HTTNPSR1
SCHEMBL2180471 0.92 HIF1A (0.42) HIF1APKMALDH1A1HTTNPSR1
SCHEMBL2181610 0.92 HIF1A (0.42) HIF1APKMALDH1A1HTTNPSR1
SCHEMBL2183121 0.91 HIF1A (0.45) HIF1APKMALDH1A1HTTNPSR1
SCHEMBL2183378 0.88 HIF1A (0.44) HIF1APKMALDH1A1HTTNPSR1
SCHEMBL2183341 0.87 ALDH1A1 (0.46) HIF1APKMALDH1A1HTTNPSR1
SCHEMBL2183775 0.86 ADORA2A (0.46) HIF1APKMALDH1A1HTTNPSR1
SCHEMBL2180453 0.86 ALDH1A1 (0.46) HIF1APKMALDH1A1HTTNPSR1
SCHEMBL2182957 0.85 HIF1A (0.45) HIF1APKMALDH1A1HTTNPSR1
SCHEMBL2183650 0.84 HIF1A (0.44) HIF1APKMALDH1A1HTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110166144-A1 Pyrimidotriazinediones and Pyrimidopyrimidinediones and Methods of Using the Same THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2011-07-07 US disclosed
WO-2010014798-A2 PYRIMIDOTRIAZINEDIONES AND PYRIMIDOPYRIMIDINEDIONES AND METHODS OF USING THE SAME THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2010-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166144-A1 Pyrimidotriazinediones and Pyrimidopyrimidinediones and Methods of Using the Same DPYD, TYMP, DHFR HIF1A 3662/4885PKM 1278/4885ALDH1A1 245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.